237761-79-4 Usage
General Description
2,3,5-Trifluorocinnamic Acid (TCFA) is a type of organic compound that belongs to the class of compounds known as benzenoids. Its molecular formula is C9H5F3O2. It is characterized by its white crystalline appearance and is soluble in many organic solvents. As its name suggests, it contains three fluorine atoms, which contribute to its reactivity. The potential applications of 2,3,5-Trifluorocinnamic Acid are primarily in the field of synthetic organic chemistry, particularly as an intermediate in the synthesis of more complex chemical compounds. It's also used in the pharmaceutical industry in drug synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 237761-79-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,7,7,6 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 237761-79:
(8*2)+(7*3)+(6*7)+(5*7)+(4*6)+(3*1)+(2*7)+(1*9)=164
164 % 10 = 4
So 237761-79-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H5F3O2/c10-6-3-5(1-2-8(13)14)9(12)7(11)4-6/h1-4H,(H,13,14)/b2-1+
237761-79-4Relevant articles and documents
5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES
-
Page/Page column 39, (2008/12/06)
The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I),wherein X represents CH2 or O; R1 represents a phenyl group, which group is independently mono-, di-, or tri-substituted wherein the substituents are independently selected from the group consisting of (C1-4)alkyl, (C1-4)alkoxy, halogen, cyano, trifluoromethoxy and trifluoromethyl; R2 represents (C1-4)alkyl, (C1-4)alkoxy, (C2-4)alkenyl, halogen, cyano, hydroxymethyl, trifluoromethyl, C(O)NR5R6 or cyclopropyl; R3 represents (C1-4)alkyl, (C1-4)alkoxy-methyl or halogen; R4 represents (C1-4)alkyl; R5 represents hydrogen or (C1-4)alkyl; and R6 represents hydrogen or (C1-4)alkyl. The invention also relates to pharmaceutically acceptable salts of such compounds; and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
